Latest stories on NVS
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
PR Newswire55 · neutralgeneral
Market Digest: NVS, CB, AVB, BYD, CMCSA, GPC, SAP
Yahoo Top50 · neutralgeneral
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Yahoo Top63 · neutralm&a
Novartis: The Buy Thesis Is Back (Rating Upgrade)
Seeking Alpha67 · bullishanalyst
Novartis (NVS) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Novartis AG (NVS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Health Care Roundup: Market Talk
Yahoo Top50 · neutralgeneral
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
CNBC50 · neutralgeneral
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
CNBC50 · neutralgeneral
Novartis backs full year forecast after $6 billion profit beat helped by one-offs
Investing.com Markets63 · neutralearnings
Novartis Q2 Earnings Call Highlights
Yahoo Finance63 · neutralearnings
Novartis rises as Q2 results beat on both lines
Seeking Alpha68 · bullishearnings
Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth - qz.com
Quartz68 · bullishearnings
Novartis returns to sales growth as cancer and MS drugs offset Entresto's steep decline
Quartz63 · neutralearnings
Novartis Q2 2026 earnings beat as cancer, MS drugs drive growth
Yahoo Finance68 · bullishearnings
Novartis Bounds For Buy Point. Why Shares Are On The Rise.
Investors.com63 · neutralgeneral
Novartis Stock Bounds For Buy Point; Why Shares Are On The Rise
Investors.com63 · neutralgeneral
Novartis Returns to Growth After Key Drugs Offset Patent Expirations — Update
Morningstar63 · neutralproduct/pr
Novartis Returns to Growth on Sales Momentum From Key Drugs
Morningstar67 · bullishearnings
Novartis Q2 profits recover as revenue mantle passes to newer medicines
Yahoo Finance63 · neutralearnings
Novartis CEO says will stay with drugmaker for next growth phase
Investing.com Markets65 · bullishgeneral
Stocks making the biggest moves premarket: General Motors, 3M, Novartis, Nebius & more
CNBC50 · neutralgeneral
Stocks making the biggest moves premarket: General Motors, 3M, Novartis, Nebius & more
CNBC50 · neutralgeneral
Novartis returns to sales growth in Q2 as newer medicines offset generic pressure (NVS)
InvestorsHub63 · neutralearnings